Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-20 08:14 am Purchase | 2026-02-12 | 13G | TYRA BIOSCIENCES INC TYRA | Farallon Capital Partners, L.P. | 2,984,818 5.600% | 2,984,818 (New Position) | Filing History |
| 2026-02-09 08:56 am Purchase | 2025-12-31 | 13G | LIQUIDIA CORPORATION COM LQDA | Farallon Capital Partners, L.P. | 8,656,038 9.900% | 90,400 (+1.06%) | Filing History |
| 2026-02-09 08:54 am Sale | 2025-12-31 | 13G | AGIOS PHARMACEUTICALS INC AGIO | Farallon Capital Partners, L.P. | 5,159,505 8.800% | -514,961 (-9.08%) | Filing History |
| 2026-02-09 08:53 am Purchase | 2025-12-31 | 13G | REVOLUTION MEDICINES INC RVMD | Farallon Capital Partners, L.P. | 14,596,149 7.500% | 1,334,104 (+10.06%) | Filing History |
| 2026-02-09 08:51 am Purchase | 2025-12-31 | 13G | BETA BIONICS INC BBNX | Farallon Capital Partners, L.P. | 4,379,920 9.900% | 176,000 (+4.19%) | Filing History |
| 2026-02-09 08:49 am Purchase | 2025-12-31 | 13G | GRAIL INC GRAL | Farallon Capital Partners, L.P. | 2,342,684 5.900% | 163,000 (+7.48%) | Filing History |
| 2026-02-09 08:46 am Purchase | 2025-12-31 | 13G | ASSEMBLY BIOSCIENCES INC N ASMB | Farallon Capital Partners, L.P. | 1,227,590 7.800% | 87,080 (+7.64%) | Filing History |
| 2026-02-06 4:10 pm Purchase | 2025-12-31 | 13G | PROTAGONIST THERAPEUTICS INC C PTGX | Farallon Capital Partners, L.P. | 6,248,013 9.990% | 291,525 (+4.89%) | Filing History |
| 2026-02-05 2:59 pm Purchase | 2025-12-31 | 13G | PERSPECTIVE THERAPEUTICS, INC. CATX | Farallon Capital Partners, L.P. | 5,427,479 8.200% | 1,950,252 (+56.09%) | Filing History |
| 2026-02-05 2:56 pm Purchase | 2025-12-31 | 13G | BEAM THERAPEUTICS INC BEAM | Farallon Capital Partners, L.P. | 10,141,856 9.990% | 168,876 (+1.69%) | Filing History |
| 2026-02-05 2:54 pm Sale | 2025-12-31 | 13G | SAVARA INC SVRA | Farallon Capital Partners, L.P. | 15,000,000 6.900% | -3,288,986 (-17.98%) | Filing History |
| 2026-02-05 2:51 pm Unchanged | 2025-12-31 | 13G | MINERVA NEUROSCIENCES INC NERV | Farallon Capital Partners, L.P. | 4,539,854 9.990% | 0 (Unchanged) | Filing History |
| 2026-02-05 2:48 pm Purchase | 2025-12-31 | 13G | ENANTA PHARMACEUTICALS INC ENTA | Farallon Capital Partners, L.P. | 2,816,862 9.800% | 708,600 (+33.61%) | Filing History |
| 2026-02-05 2:45 pm Purchase | 2025-12-31 | 13G | CRINETICS PHARMACEUTICALS INC CRNX | Farallon Capital Partners, L.P. | 8,024,098 8.500% | 2,399,000 (+42.65%) | Filing History |
| 2026-01-05 6:05 pm Sale | 2026-01-01 | 13D | EXELIXIS INC EXEL | Farallon Capital Partners, L.P. | 15,709,500 5.900% | -2,926,000 (-15.70%) | Filing History |
| 2025-12-29 4:05 pm Purchase | 2025-12-22 | 13G | MINERVA NEUROSCIENCES INC NERV | Farallon Capital Partners, L.P. | 4,539,854 9.990% | 4,539,854 (New Position) | Filing History |
| 2025-11-24 7:25 pm Purchase | 2025-11-17 | 13G | GRAIL INC GRAL | Farallon Capital Partners, L.P. | 2,179,684 5.500% | 232,000 (+11.91%) | Filing History |
| 2025-11-13 09:46 am Purchase | 2025-10-21 | 13G | GRAIL INC GRAL | Farallon Capital Partners, L.P. | 1,947,684 4.900% | 1,947,684 (New Position) | Filing History |
| 2025-11-12 12:22 pm Sale | 2025-09-30 | 13G | PERSPECTIVE THERAPEUTICS, INC. CATX | Farallon Capital Partners, L.P. | 3,477,227 5.100% | -2,546,000 (-42.27%) | Filing History |
| 2025-11-12 12:17 pm Purchase | 2025-09-30 | 13G | TANGO THERAPEUTICS INC TNGX | Farallon Capital Partners, L.P. | 10,757,000 9.700% | 1,600,000 (+17.47%) | Filing History |